Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting.
- Resource Type
- Article
- Source
- Applied Health Economics & Health Policy; Jul2022, Vol. 20 Issue 4, p543-555, 13p
- Subject
- Language
- ISSN
- 11755652